Chronic hepatitis C
Do you want to receive a message when new research on Chronic hepatitis C is available? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, every publication shows one sentence explaining what was studied — and you'll receive a notification as soon as new research on Chronic hepatitis C is available. View what Premium costs.
Publications (1342)
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Hepatocellular Carcinoma Invading the Gastric Antrum. (2019/08/01) ♡
- Association of chronic inflammation and perceived stress with abnormal functional connectivity in brain areas involved with interoception in hepatitis C patients. (2019/08/01) ♡
- Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents. (2019/08/01) ♡
- Comparison and correlation of fibrosis stage assessment by collagen proportionate area (CPA) and the ELF panel in patients with chronic liver disease. (2019/07/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Improvement of Central Nervous System Vasculitis in a Patient with Chronic Hepatitis C Virus Infection after Treatment with an Interferon-Free Regimen. (2019/07/01) ♡
- Comparing drug interaction frequencies of various hepatitis C treatment regimens among monoinfected patients. (2019/07/01) ♡
- Muscle performance and fatigue in compensated chronic liver disease. (2019/07/01) ♡
- Factors associated with vitamin D deficiency in HIV-1 infected patients on combination antiretroviral therapy: a case-control study. (2019/07/01) ♡
- Serum miR-483-5p and miR-133a as Biomarkers for Diagnosis of Hepatocellular Carcinoma Post-Hepatitis C Infection in Egyptian Patients. (2019/07/01) ♡
- Association of Treg and TH17 Cytokines with HCV Pathogenesis and Liver Pathology. (2019/07/01) ♡
- Inducible Nitric Oxide Synthase Polymorphism In Hepatitis C Patients Treated With Interferon Based-Treatment As A Predictor of Early Virological Response. (2019/07/01) ♡
- Evaluation of aspartate aminotransferase to platelet ratio index and fibrosis 4 scores for hepatic fibrosis assessment compared with transient elastography in chronic hepatitis C patients. (2019/06/26) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Role of Micronutrients in the Infection and Subsequent Response to Hepatitis C Virus. (2019/06/17) ♡
- Liver cancer: A leading cause of cancer death in the United States and the role of the 1945-1965 birth cohort by ethnicity. (2019/06/17) ♡
- The association of hepatitis c virus infection status with serum glucose levels. (2019/06/13) ♡
- Treatment with direct-acting antivirals improves peripheral insulin sensitivity in non-diabetic, lean chronic hepatitis C patients. (2019/06/06) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hepatitis C virus therapy: No one will be left behind. (2019/06/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Syndrome of inappropriate antidiuretic hormone secretion following transarterial chemoembolisation of hepatocellular carcinoma. (2019/06/01) ♡
- Early high levels of regulatory T cells and T helper 1 may predict the progression of recurrent hepatitis C after liver transplantation. (2019/06/01) ♡
- Vitamin D deficiency and health-related quality of life in chronic hepatitis C. (2019/06/01) ♡
- Elevated serum levels of adiponectin and interlukin-28B after IFN/RIB therapy in hepatitis C virus-infected patients. (2019/05/31) ♡
- IL-28B genotypes as predictors of long-term outcome in patients with hepatitis C-related severe liver injury. (2019/05/31) ♡
- Cutoff Values of Acoustic Radiation Force Impulse Two-Location Measurements in Different Etiologies of Liver Fibrosis. (2019/05/17) ♡
- An evaluation of the hepatitis C testing, care and treatment program in the country of Georgia's corrections system, December 2013 - April 2015. (2019/05/10) ♡
- HCV infection causes cirrhosis in human by step-wise regulation of host genes involved in cellular functioning and defense during fibrosis: Identification of bio-markers. (2019/05/08) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Quality of life in patients with chronic hepatitis C infection: Severe comorbidities and disease perception matter more than liver-disease stage. (2019/05/03) ♡
- Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection. (2019/05/01) ♡
- Strategy and Efficacy of Generic and Pan-genotypic Sofosbuvir/Velpatasvir in Chronic Hepatitis C Virus: A Myanmar Experience. (2019/05/01) ♡
- New direct-acting antivirals for hepatitis C treatment and neuropsychiatric symptoms in psychiatric risk groups. (2019/05/01) ♡
- Awareness of chronic viral hepatitis in the United States: An update from the National Health and Nutrition Examination Survey. (2019/05/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study. (2019/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Antioxidants benefits in hepatitis C infection in the new DAAs era. (2019/05/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. (2019/04/06) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Pentraxin 3 Detects Clinically Significant Fibrosis in Patients with Chronic Viral Hepatitis C. (2019/04/02) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The Successful Retreatment with Glecaprevir and Pibrentasvir of Genotype 1 or 2 HCV-infected Hemodialysis Patients who Failed to Respond to NS5A and Protease Inhibitor Treatment. (2019/04/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Diagnosis of hepatitis C virus infection in Spain: An opportunity to improve. (2019/04/01) ♡
- Neuropsychiatric symptoms in hepatitis C patients resemble those of patients with autoimmune liver disease but are different from those in hepatitis B patients. (2019/04/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Clinical management of patients with hemophilia A in nephrology: Diagnostic and therapeutic challenges illustrated by the cases of 2 patients]. (2019/04/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Does incarceration change the profile of pulmonary tuberculosis in Tunisia? (2019/04/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The health equity implementation framework: proposal and preliminary study of hepatitis C virus treatment. (2019/03/12) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Efficacy and safety of alisporivir for the treatment of hepatitis C infection. (2019/03/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Variation in hepatitis C virus treatment uptake between Canadian centres in the era of direct-acting antivirals. (2019/03/01) ♡
- microRNA-1273g-3p is a useful non-invasive test for the prediction of liver fibrosis in patients with chronic hepatitis C. (2019/03/01) ♡
- Chronic Hepatitis C and Health-Related Quality of Life in Patients with Cognitive Impairment. (2019/03/01) ♡
- Improving Health-Related Quality of Life Assessment in Chronic Hepatitis C. (2019/03/01) ♡
- Therapy with Oral Directly Acting Agents in Hepatitis C Infection Is Associated with Reduction in Fibrosis and Increase in Hepatic Steatosis on Transient Elastography. (2019/03/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Pegylated interferon and ribavirin treatment for chronic hepatitis C deteriorates subclinical markers of vascular function. (2019/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016. (2019/03/01) ♡
- Circulating microRNA-155 is associated with insulin resistance in chronic hepatitis C patients. (2019/03/01) ♡
- Glutathione peroxidase and malondialdehyde in children with chronic hepatitis C. (2019/03/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.